MONDAY, July 7, 2025 (HealthDay News) — Adults as young as 50 may now qualify for an RSV vaccine if they have certain health ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The CDC director typically signs off on the panel's recommendations before they are implemented, but the agency does not currently have one. President Donald Trump 's nominee for the post, Susan ...

CDC vaccine advisory panel to study child immunization schedule, recommends RSV shot for babies The meeting was the first made up of RFK Jr.'s new hand-selected members.

CDC vaccine advisers recommend Merck’s RSV therapy for babies The vote was the first for the new members of the committee, who had been handpicked by health secretary Robert F. Kennedy Jr. Merck ...

Meissner also expressed how thoroughly the CDC panel’s work group on RSV examined the data. “We went through the details very, very carefully, and I appreciate Dr. [Levi’s] careful review of ...

CDC advisers recommend Merck's Enflonsia to protect babies from RSV, addressing the leading cause of infant hospitalization ...

The CDC noted that, at this time, RSV vaccination is recommended as a single dose only. People who have already received an RSV vaccination are not recommended to receive another dose.

The U.S. CDC recommends RSV vaccines for high-risk adults aged 50-59, endorsing the views of the former vaccine advisory panel. Read more here.